TRT and Fertility: Where hCG Fits

Standard testosterone replacement therapy (TRT) can significantly suppress fertility, because adding testosterone from outside the body tells the brain to switch off the hormones that drive your own testosterone and sperm production. This is one of the most important facts for any man of reproductive age to understand before starting. hCG, a prescription medication that mimics the body's signal to the testes, is commonly used alongside TRT to help preserve fertility and testicular function. TRT and hCG are prescription therapies (testosterone is a Schedule III controlled substance) that require a diagnosis and ongoing monitoring; any protocol here is decided and managed by a licensed clinician, and this is education, not medical advice.

Why TRT suppresses fertility

Your testosterone and sperm production are controlled by a feedback loop called the hypothalamic-pituitary-gonadal (HPG) axis. The hypothalamus releases GnRH, which prompts the pituitary to release two hormones: luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH tells the testes to make testosterone; FSH supports sperm production (spermatogenesis).

When you take exogenous testosterone, the brain senses that testosterone levels are high and dials down GnRH. That reduces LH and FSH, which in turn reduces the testes' own testosterone output and their sperm production. The downstream results can include testicular atrophy (shrinkage), reduced sperm count, and in some cases azoospermia, meaning no measurable sperm in the ejaculate.

This is not an immediate switch. The effect is dose- and duration-dependent and develops over weeks to months. That gradual onset is part of why it catches people off guard: TRT may make someone feel better while quietly suppressing the fertility axis in the background. It is exactly the kind of consequence that belongs in the conversation before the first injection, not after.

Where hCG fits

hCG (human chorionic gonadotropin) is the key tool for keeping the testes engaged while on TRT. Structurally, it acts like LH: it binds the same receptors and stimulates the Leydig cells in the testes to keep producing testosterone locally and to maintain testicular volume and function.

The practical effect is that hCG can keep the testes "switched on" even while exogenous testosterone is suppressing the body's own LH. That helps preserve testicular size and supports the intratesticular testosterone environment that spermatogenesis depends on. For men who want to protect fertility or simply avoid testicular atrophy, hCG is the most common addition to a TRT protocol.

One important nuance: hCG does not reliably restore full spermatogenesis on its own in every man. Because FSH also plays a central role in sperm production, some men need FSH supplementation as well, or a different approach entirely, to fully maintain or recover sperm counts. These decisions sit with a reproductive endocrinologist or a urologist, not with an article or a forum. hCG is a prescription medication, and the protocol around it is individualized.

Comparing fertility-preservation approaches

The table below outlines the main approaches men discuss with clinicians when fertility is a priority on or instead of TRT. It compares mechanisms and considerations, not doses; doses are set by a provider.

Approach	How it works	Key considerations
TRT plus hCG	hCG mimics LH to keep the testes producing testosterone and maintaining volume while on testosterone	Helps preserve testicular function and fertility for many men; may not fully maintain sperm counts alone; FSH sometimes added
Lower-frequency or adjusted TRT strategies	Provider-led dose and schedule choices that aim to balance symptom control with axis suppression	Does not eliminate suppression; an adjustment, not a fertility guarantee; individualized
Enclomiphene (off-label alternative to TRT)	Stimulates the body's own LH and FSH rather than supplying testosterone, generally preserving fertility	Not FDA-approved; works only with an intact, responsive pituitary and testes; oral; covered in our comparison below

The right path depends on your diagnosis, your goals, and your timeline for wanting children, which is why it is a clinical decision. Our enclomiphene versus TRT comparison goes deeper on that fork in the road.

The enclomiphene alternative

For men who want to protect fertility, an alternative to standard TRT is sometimes considered: enclomiphene, a selective estrogen receptor modulator. Instead of supplying testosterone from outside, it blocks estrogen's negative feedback on the brain, which raises GnRH and therefore LH and FSH, prompting the body to make more of its own testosterone. Because it works through the natural axis rather than overriding it, it generally preserves, and may even improve, fertility markers.

The important caveats: enclomiphene is not FDA-approved and is used off-label through compounding pharmacies and telehealth, and it only works if the pituitary and testes can respond, which is the case in secondary hypogonadism but not primary. Whether it is appropriate is a clinical judgment based on confirmed labs and goals. Our signs of low testosterone article covers why those labs come first.

Recovery of fertility after stopping TRT

A common question is whether fertility returns after stopping testosterone. For most men, spermatogenesis does recover after TRT cessation, but the honest framing has three caveats: recovery is not guaranteed, it can take months to years, and a minority of men may not fully recover. Longer duration and higher doses generally lengthen the timeline.

Because of that uncertainty, two strategies come up repeatedly in clinical conversations: banking sperm before starting TRT, which preserves the option regardless of what happens later, and using fertility-preserving agents like hCG during therapy. Neither is something to improvise. They are planned with a provider, ideally before the first dose.

Why FSH sometimes enters the picture

The reason hCG alone does not always fully maintain fertility comes back to the two-signal nature of the system. LH, which hCG mimics, drives the testosterone production inside the testes that spermatogenesis depends on, but FSH directly supports the Sertoli cells that nurture developing sperm. In some men, keeping LH-like signaling going with hCG is enough; in others, sperm production also needs the FSH side of the equation supported.

That is why a reproductive specialist managing a complex case may add FSH, or use a SERM like clomiphene or enclomiphene that raises both LH and FSH, rather than relying on hCG by itself. The right combination is individual and depends on a man's baseline, how suppressed his system already is, and his goals and timeline. This is firmly specialist territory, which is the point: fertility on or after TRT is not a do-it-yourself protocol, it is a clinical plan built around your specific hormones and aims.

Testicular atrophy versus fertility: related but not identical

A common point of confusion is conflating testicular shrinkage with infertility. They are linked, since both stem from the testes being under-stimulated when exogenous testosterone suppresses LH, but they are not the same thing. Testicular atrophy is the visible, physical shrinkage some men notice on TRT, while infertility is about sperm production specifically.

hCG addresses both at once, because keeping the testes stimulated tends to preserve their size and their function together. That is part of why some men add hCG even when fertility is not their main concern, simply to maintain testicular volume. But preserving size does not automatically guarantee a normal sperm count, which is why the fertility question still needs its own labs, such as a semen analysis, rather than being judged by how the testes look or feel. Your clinician decides what to measure and when.

Timing: why "before you start" matters so much

The single most actionable point in this whole topic is timing. Because TRT-induced suppression develops over weeks to months and recovery is uncertain, the decisions with the most leverage are the ones made before the first dose, not after sperm counts have already fallen.

A man who banks sperm before starting has secured the option regardless of what therapy does to his fertility later. A man who starts hCG alongside TRT from the beginning is more likely to maintain testicular function than one who tries to add it after months of suppression. And a man who simply has the fertility conversation up front can make an informed choice between standard TRT, TRT plus hCG, or an axis-preserving alternative like enclomiphene. The cost of skipping that conversation is that some of these options narrow or close once suppression has set in. This is exactly the kind of decision that belongs with a clinician at the very start of care.

A common misconception: "TRT is birth control"

One dangerous misreading deserves a direct correction. Because TRT suppresses sperm production, some men assume it functions as reliable contraception. It does not. The suppression is variable and incomplete in many men, sperm counts can remain high enough to cause a pregnancy, and the degree of suppression is unpredictable from person to person.

Treating TRT as birth control is how unplanned pregnancies happen, and it is exactly backward from how the fertility risk actually works: TRT is unreliable at suppressing fertility for contraceptive purposes, yet capable of impairing it for family-planning purposes. Both of those can be true at once. The safe framing is that TRT is neither a contraceptive nor a guarantee of infertility, and anyone relying on it for either purpose should talk to a clinician instead of assuming.

What to ask a provider

Helpful questions for a clinician include: How is my fertility likely to be affected by TRT given my age and goals? Should I bank sperm before starting? Would hCG, with or without FSH, fit my protocol if I want to preserve fertility? And is an alternative like enclomiphene a better fit for my diagnosis? A clinician experienced in men's hormonal and reproductive health can answer these against your labs and history.

The tracking angle

A fertility-conscious TRT protocol often means more than one injectable on different schedules, for example testosterone plus hCG, which is easy to let slip. Myo keeps both in a single schedule with reminders and an injection log, so the fertility-preservation piece stays on track rather than getting dropped. It also stores the bloodwork your clinician monitors over time. Myo organizes a provider-directed protocol; it never prescribes, sources medication, or replaces your clinician's judgment.

References

• Endocrine Society. Testosterone Therapy in Men With Hypogonadism: Clinical Practice Guideline. endocrine.org.
• ReUp Men's Clinic and Alpha MD educational overviews of hCG, enclomiphene, and clomiphene roles in male hormone therapy.
• Reproductive Biology and Endocrinology. Published data on enclomiphene preserving LH and FSH versus exogenous testosterone.
• World Journal of Men's Health. British Society for Sexual Medicine position statement on enclomiphene, 2026.